PT3283171T - Derivados de anfotericina b - Google Patents
Derivados de anfotericina bInfo
- Publication number
- PT3283171T PT3283171T PT167808138T PT16780813T PT3283171T PT 3283171 T PT3283171 T PT 3283171T PT 167808138 T PT167808138 T PT 167808138T PT 16780813 T PT16780813 T PT 16780813T PT 3283171 T PT3283171 T PT 3283171T
- Authority
- PT
- Portugal
- Prior art keywords
- amphotericin
- derivatives
- Prior art date
Links
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical class O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562147949P | 2015-04-15 | 2015-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3283171T true PT3283171T (pt) | 2021-07-14 |
Family
ID=57126898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167808138T PT3283171T (pt) | 2015-04-15 | 2016-04-15 | Derivados de anfotericina b |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9957290B2 (enExample) |
| EP (2) | EP3283171B1 (enExample) |
| JP (3) | JP7240811B2 (enExample) |
| CA (2) | CA3021061C (enExample) |
| ES (1) | ES2880029T3 (enExample) |
| PT (1) | PT3283171T (enExample) |
| WO (1) | WO2016168568A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102548341B1 (ko) | 2013-10-07 | 2023-06-26 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 개선된 치료 지수를 갖는 암포테리신 b 유도체 |
| MA39568A1 (fr) | 2014-06-12 | 2017-09-29 | Shionogi & Co | Dérivé de macrolide de polyène |
| JP7240811B2 (ja) * | 2015-04-15 | 2023-03-16 | スファンガ セラピューティクス インコーポレイテッド | アムホテリシンｂの誘導体 |
| WO2017100171A1 (en) * | 2015-12-08 | 2017-06-15 | Kalyra Pharmaceuticals, Inc. | Antifungal compounds and methods |
| WO2018106571A1 (en) * | 2016-12-06 | 2018-06-14 | Kalyra Pharmaceuticals, Inc. | Antifungal compounds and methods |
| CA3111565A1 (en) * | 2018-09-07 | 2020-03-12 | The Board Of Trustees Of The University Of Illinois | Hybrid amphotericin b derivatives with reduced toxicity |
| KR20220058547A (ko) * | 2019-08-08 | 2022-05-09 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 감소된 독성을 갖는 하이브리드 암포테리신 b 유도체 |
| EP4009985A4 (en) * | 2019-08-08 | 2023-09-06 | The Board Of Trustees Of The University Of Illinois | HYBRID AMIDE DERIVATIVES OF AMPHOTERICIN B |
| FR3112145A1 (fr) * | 2020-07-03 | 2022-01-07 | Nanotracks Diagnostics | Derives uree de macrolides polyeniques, composes chimiques particuliers susceptibles d’etre utilises pour obtenir ces derives uree, compositions les contenant et utilisations |
| WO2022003181A1 (fr) * | 2020-07-03 | 2022-01-06 | Nanotracks Diagnostics | Derivés urée de l'amphotéricine amb, compositions les contenant et leurs utilisations, dérivés isocyanate d'alkyle omega-aminés et leur utilisation pour obtenir lesdits dérivés urée |
| AU2021325676A1 (en) * | 2020-08-10 | 2023-03-30 | The Board Of Trustees Of The University Of Illinois | Hybrid amide derivatives of amphotericin B |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8829592D0 (en) | 1988-12-19 | 1989-02-08 | Beecham Group Plc | Novel compounds |
| EP0350164A3 (en) * | 1988-06-13 | 1991-07-24 | Beecham Group Plc | Amphotericin derivatives |
| EP0431870A1 (en) * | 1989-12-08 | 1991-06-12 | Beecham Group p.l.c. | Amphotericin B derivatives |
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| GB9203476D0 (en) | 1992-02-19 | 1992-04-08 | Smithkline Beecham Plc | Novel compounds |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| US5606038A (en) | 1995-04-10 | 1997-02-25 | Competitive Technologies, Inc. | Amphiphilic polyene macrolide antibiotic compounds |
| PL180253B1 (pl) * | 1995-05-13 | 2001-01-31 | Politechnika Gdanska | Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL |
| US6664241B2 (en) | 2000-05-31 | 2003-12-16 | Micrologix Biotech Inc. | Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof |
| WO2007096137A1 (en) * | 2006-02-23 | 2007-08-30 | Eth Zurich | Amphotericin derivatives |
| JP5240704B2 (ja) * | 2007-10-05 | 2013-07-17 | 国立大学法人群馬大学 | 新規蛍光化合物およびそれを用いた細胞内コレステロールの検出方法 |
| KR20150027217A (ko) * | 2012-06-15 | 2015-03-11 | 블러트 에스.에이. | 항진균성 항생 암포테리신 b의 n-치환된 제2 세대 유도체, 및 이의 제조 및 응용 방법 |
| WO2014165676A1 (en) | 2013-04-03 | 2014-10-09 | The Board Of Trustees Of The University Of Illinois | Amphotericin b derivative with reduced toxicity |
| KR102548341B1 (ko) | 2013-10-07 | 2023-06-26 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 개선된 치료 지수를 갖는 암포테리신 b 유도체 |
| WO2015164289A1 (en) * | 2014-04-21 | 2015-10-29 | Cidara Therapeutics, Inc. | Compositions and methods for the treatment of fungal infections |
| ES2749927T3 (es) | 2014-05-16 | 2020-03-24 | Univ Illinois | Derivado de anfotericina b con toxicidad reducida |
| MA39568A1 (fr) * | 2014-06-12 | 2017-09-29 | Shionogi & Co | Dérivé de macrolide de polyène |
| WO2016014779A1 (en) | 2014-07-23 | 2016-01-28 | The Board Of Trustees Of The University Of Illinois | Antifungal polyene macrolide derivatives with reduced mammalian toxicity |
| WO2016040779A1 (en) | 2014-09-12 | 2016-03-17 | The Board Of Trustees Of The University Of Illinois | Urea derivatives of polyene macrolide antibiotics |
| WO2016061437A1 (en) | 2014-10-17 | 2016-04-21 | The Board Of Trustees Of The University Of Illinois | Scalable synthesis of reduced toxicity derivative of amphotericin b |
| WO2016112260A1 (en) * | 2015-01-08 | 2016-07-14 | The Board Of Trustees Of The University Of Illinois | Concise synthesis of urea derivatives of amphotericin b |
| WO2016112243A1 (en) | 2015-01-08 | 2016-07-14 | The Board Of Trustees Of The University Of Illinois | Urea derivatives of amphotericin b derived from secondary amines |
| JP7240811B2 (ja) * | 2015-04-15 | 2023-03-16 | スファンガ セラピューティクス インコーポレイテッド | アムホテリシンｂの誘導体 |
-
2016
- 2016-04-15 JP JP2017553875A patent/JP7240811B2/ja active Active
- 2016-04-15 EP EP16780813.8A patent/EP3283171B1/en active Active
- 2016-04-15 WO PCT/US2016/027703 patent/WO2016168568A1/en not_active Ceased
- 2016-04-15 ES ES16780813T patent/ES2880029T3/es active Active
- 2016-04-15 CA CA3021061A patent/CA3021061C/en active Active
- 2016-04-15 US US15/099,837 patent/US9957290B2/en active Active
- 2016-04-15 PT PT167808138T patent/PT3283171T/pt unknown
- 2016-04-15 CA CA3213127A patent/CA3213127A1/en active Pending
- 2016-04-15 EP EP21175661.4A patent/EP3929203A1/en active Pending
-
2018
- 2018-04-09 US US15/948,122 patent/US10597420B2/en active Active
-
2020
- 2020-02-25 US US16/800,694 patent/US10882883B2/en active Active
-
2021
- 2021-02-16 JP JP2021022476A patent/JP2021075570A/ja not_active Abandoned
-
2022
- 2022-12-22 JP JP2022205228A patent/JP2023030103A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20160304548A1 (en) | 2016-10-20 |
| US20180273572A1 (en) | 2018-09-27 |
| EP3929203A1 (en) | 2021-12-29 |
| CA3021061A1 (en) | 2016-10-20 |
| EP3283171B1 (en) | 2021-05-26 |
| CA3213127A1 (en) | 2016-10-20 |
| JP2018514522A (ja) | 2018-06-07 |
| US9957290B2 (en) | 2018-05-01 |
| HK1244248A1 (zh) | 2018-08-03 |
| WO2016168568A1 (en) | 2016-10-20 |
| JP2021075570A (ja) | 2021-05-20 |
| CA3021061C (en) | 2023-10-24 |
| ES2880029T3 (es) | 2021-11-23 |
| US20200262858A1 (en) | 2020-08-20 |
| JP7240811B2 (ja) | 2023-03-16 |
| JP2023030103A (ja) | 2023-03-07 |
| EP3283171A4 (en) | 2019-03-13 |
| US10597420B2 (en) | 2020-03-24 |
| US10882883B2 (en) | 2021-01-05 |
| EP3283171A1 (en) | 2018-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201800826B (en) | Substituted oxopyridine derivatives | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| IL257026A (en) | Solid state forms of eluxadoline | |
| IL253381A0 (en) | History of h9-pyrrolo-dipyridine | |
| PT3283171T (pt) | Derivados de anfotericina b | |
| SMT202100551T1 (it) | Derivati di sobetirome | |
| SI3845221T1 (sl) | Trdne oblike sofosbuvirja | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| PT3334734T (pt) | Forma c de avibactam sódico | |
| PL3164393T3 (pl) | Pochodne flawaglin | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| SI3380554T2 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| IL248773A0 (en) | History of naphthyridinedione | |
| SG10202101979TA (en) | Crystalline forms of c21h22ci2n4o2 | |
| ZA201706282B (en) | Solid forms of menaquinols | |
| GB201904142D0 (en) | Improved method of FT-IMS | |
| IL251005B (en) | Pyrido-oxazinone derivatives | |
| AP2016009530A0 (en) | Cycloalkyl-linked diheterocycle derivatives | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| IL253479A0 (en) | Crystalline forms of efinconazole | |
| IL249130A0 (en) | Preparation of piperidine-4-carbthioamide | |
| SG11201804610RA (en) | Marking-out aid | |
| HUP1500506A2 (en) | Salts of palbociclib | |
| IL249332A0 (en) | Crystalline forms of sofosbuvir |